Magellan Health Reports Third Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Magellan Health (MGLN) Tops Q3 EPS by 24c, Guides FY EPS Ahead of Views
November 1, 2017 6:37 AM EDTMagellan Health (NASDAQ: MGLN) reported Q3 EPS of $1.64, $0.24 better than the analyst estimate of $1.40. Revenue for the quarter came in at $1.42 billion versus the consensus estimate of $1.49 billion.
GUIDANCE:
Magellan Health sees FY2017 EPS of $5.45-$5.86, versus the consensus of... More
